Schedule 13G ownership disclosure
Verrica Pharmaceuticals Inc.
Security class unavailable
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-018193
- Form type
- SC 13G
- Filer
- Davidson Matt
- CIK
- CIK 1741937
- Filed
- Apr 04, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership